CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 130 enrolled
Drug / intervention
Low Dose Acetazolamide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01993667
NCT01993667Phase 4Completed
CompareCT.gov

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

University of Utah·interventional·Posted Nov 25, 2013·Updated Jan 29, 2019

In Brief

A Phase 4 clinical trial evaluating Low Dose Acetazolamide and Normal Dose Acetazolamide for Prophylaxis of Acute Mountain Sickness. Completed, enrolled 130 participants across 1 site.

Detailed Summary

This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProphylaxis of Acute Mountain Sickness
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 25, 2013
Enrollment StartMar 1, 2012
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.6 years ago

Interventions

Low Dose Acetazolamidedrug

Administration of low dose acetazolamide

Normal Dose Acetazolamidedrug

Administration of normal dose acetazolamide